RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > Good Clinical Practice Compliance and the Start-up Company

Good Clinical Practice Compliance and the Start-up Company

Posted 01 May 2010

Start-up drug or device companies tend to minimize spending and occasionally to be "penny wise and pound foolish." However, when conducting clinical studies, rules must be followed to ensure the reliability of data. There are many pitfalls a start-up can fall into when first conducting clinical studies. These can be minimized or eliminated by planning the various items for a clinical study before execution and employing skilled and experienced individuals to monitor and audit the studies.

 

© 2022 Regulatory Affairs Professionals Society.